Mar 11, 2025 8:30 am EDT Kane Biotech Announces Canadian Distribution Agreement With Best Buy Medical for revyve™ Antimicrobial Wound Gel
Feb 19, 2025 8:30 am EST Kane Biotech Announces Second and Final Closing of Private Placement Offering
Jan 21, 2025 8:30 am EST Kane to Host Investor Webinar – What Kane has in Store for 2025 Including the Acquisition of FB Dermatology
Jan 20, 2025 8:30 am EST Kane Biotech Announces First Closing of Private Placement Offering and Extension of Private Placement Offering
Nov 27, 2024 8:30 am EST Kane Biotech Announces Change in US Distribution Partner for revyve™ Antimicrobial Wound Gel
Nov 21, 2024 4:30 pm EST Kane Biotech to Release Third Quarter 2024 Financial Results on November 28, 2024
Nov 14, 2024 1:10 pm EST Kane Biotech Announces Health Canada Approval of revyve™ Antimicrobial Wound Gel
Nov 14, 2024 8:30 am EST Kane Biotech Provides Investor Update Following FB Dermatology Acquisition Announcement
